Amylin Shoots Up On Takeover Rumors
Amylin Pharmaceutical (NASDAQ:AMLN) shares shot up 54.45% on rumors regarding a take-over bid by Bristol-Myers Squibb (NYSE:BMY). According to Bloomberg, which cited unnamed sources, Bristol-Myers had made an offer of $22 per share ($3.5 billion). However, the offer was rejected by Amylin’s board of directors last month. Why Amylin? Following the termination of Amylin’s exenatide [...]
Amylin Pharmaceutical (NASDAQ:AMLN) shares shot up 54.45% on rumors regarding a take-over bid by Bristol-Myers Squibb (NYSE:BMY). According to Bloomberg, which cited unnamed sources, Bristol-Myers had made an offer of $22 per share ($3.5 billion). However, the offer was rejected by Amylin’s board of directors last month.
Why Amylin?
Following the termination of Amylin’s exenatide agreement with Eli Lilly (NYSE:LLY) in November 2011, Amylin has been considered to be a potential takeover candidate for … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards